Explore more publications!
Health Industry Watch
Got News to Share?

Press Releases

How to transform patient safety in mental health settings
17 minutes ago

How to transform patient safety in mental health settings

Neutral Rethink Mental Illness
Owner: Rethink Mental Illness (Non-profit)

Rethink Mental Illness

Neutral
Owned By Rethink Mental Illness (Non-profit, Mark Winstanley Chief Executive)
Year Founded 1970
Website www.rethink.org
Domain Registration Year Indeterminate
Access Type open
Publication Location United Kingdom, London
Owner Country United Kingdom

We welcome your feedback!
If you have comments or corrections, let us know.

Nasus Pharma to Participate in Upcoming Investor Conferences
2 hours ago

Nasus Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire, Inc.
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
3 hours ago

Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th

Indeterminate GlobeNewswire, Inc.
Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements
an hour ago

Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements

Indeterminate GlobeNewswire, Inc.
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
3 hours ago

BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference

Indeterminate GlobeNewswire, Inc.
SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings
an hour ago

SRx Health Solutions Increases Ownership of Opendoor Technologies by 30% and is Now Net Long Cryptocurrency Holdings

Indeterminate GlobeNewswire, Inc.
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
an hour ago

Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

Indeterminate GlobeNewswire, Inc.
SRx Health Solutions Announces Receipt of Warning Letter from NYSE American
2 hours ago

SRx Health Solutions Announces Receipt of Warning Letter from NYSE American

Indeterminate GlobeNewswire, Inc.
Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers
3 hours ago

Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers

Indeterminate GlobeNewswire, Inc.
Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
3 hours ago

Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire, Inc.
TexanBox Expands Ecommerce and Business Packaging Solutions Across Central Texas
3 hours ago

TexanBox Expands Ecommerce and Business Packaging Solutions Across Central Texas

Neutral EIN Presswire
Mesoblast Financial Results and Corporate Update Webcast
3 hours ago

Mesoblast Financial Results and Corporate Update Webcast

Indeterminate GlobeNewswire, Inc.
OTC Markets Group Welcomes IEH Corporation to OTCQX
3 hours ago

OTC Markets Group Welcomes IEH Corporation to OTCQX

Indeterminate GlobeNewswire, Inc.
New CAPC Report Identifies Caregiver Support as Key to Better Outcomes and Lower Health Care Costs
an hour ago

New CAPC Report Identifies Caregiver Support as Key to Better Outcomes and Lower Health Care Costs

Indeterminate GlobeNewswire, Inc.
Good News for Tacoma Seniors: Beyond Ride and Wesley Bradley Park Point Toward More Connected Medical Transportation
3 hours ago

Good News for Tacoma Seniors: Beyond Ride and Wesley Bradley Park Point Toward More Connected Medical Transportation

Neutral EIN Presswire
Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG
4 hours ago

Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG

Neutral EIN Presswire
Hilltop Behavioral Health Announces Expanded Eating Disorder Care for Men, Athletes and Families
3 hours ago

Hilltop Behavioral Health Announces Expanded Eating Disorder Care for Men, Athletes and Families

Indeterminate GlobeNewswire, Inc.
Global IT, NCIO Review Urge L.A. Boards: Cybersecurity Is a Business Decision
an hour ago

Global IT, NCIO Review Urge L.A. Boards: Cybersecurity Is a Business Decision

Neutral EIN Presswire
Traini’s Sentra Smart Collar Ranked #1 AI Hardware Product at CES 2026; Company Secures $7.5M to Expand Pet Emotion AI Platform
6 hours ago

Traini’s Sentra Smart Collar Ranked #1 AI Hardware Product at CES 2026; Company Secures $7.5M to Expand Pet Emotion AI Platform

Indeterminate GlobeNewswire, Inc.
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
7 hours ago

O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions